Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insemination in PCOS: letrozole vs gonadotropins
2023-503477-38-00Phase 3Authorised
- Sponsor
- Hospital Universitario La Paz
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of letrozole, follitropin alfa, follitropin beta and recombinant human follicle stimulating hormone in polycystic ovary syndrome (PCOS) and female infertility (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoints: Gestation rate per insemination and Newborn rate per insemination. Planned start Oct 2023; status: authorised.
02
Drugs
letrozolefollitropin alfafollitropin betarecombinant human follicle stimulating hormone
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on 2023-503477-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503477-38-00.